Market Exclusive

Analyst Downgrades – NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT) Stock Gets Downgraded By Stifel Nicolaus from Buy ➝ Hold to

Analyst Ratings For NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT)

Today, NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT) stock was downgraded by Stifel Nicolaus from Buy ➝ Hold to with a price target of $20.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT)
NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT) has insider ownership of 15.00% and institutional ownership of 76.46%.

Recent Trading Activity for NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT)
Shares of NASDAQ:CORT – Corcept Therapeutics closed the previous trading session at 18.38 down -1.31 6.65% with 18.27079963684082 shares trading hands.

Exit mobile version